Evidence map›Paper›PMID 31485369›Full record

ArticleJournal of analytical methods in chemistry2019

Quantitative Analysis of Eight Triterpenoids and Two Sesquiterpenoids in Rhizoma Alismatis by Using UPLC-ESI/APCI-MS/MS and Its Application to Optimisation of Best Harvest Time and Crude Processing Temperature.

Yanni Tai, Fuxian Zou, Qiurong Zhang, Jia Wang, Ronghui Rao, Ruihua Xie, Shuisheng Wu, Kedan Chu, Wen Xu, Xiaoyan Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of analytical methods in chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Changes in Triterpenes inMolecules (Basel, Switzerland) · 2021
    Article
  4. Quantitative Determination ofJournal of analytical methods in chemistry · 2021
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yanni TaiCollege of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.ORCID https://orcid.org/0000-0002-4471-2881
Fuxian ZouCollege of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.ORCID https://orcid.org/0000-0003-0442-4102
Qiurong ZhangCollege of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.
Jia WangCollege of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.
Ronghui RaoNanping Institute of Agricultural Sciences of Fujian Province, Jianyang 354200, Fujian, China.
Ruihua XieCollege of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.
Shuisheng WuCollege of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.
Kedan ChuCollege of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.
Wen XuCollege of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.ORCID https://orcid.org/0000-0001-7126-8029
Xiaoyan LiCollege of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.ORCID https://orcid.org/0000-0002-0873-2594
Mingqing HuangCollege of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.
Fujian University of Traditional Chinese Medicine · CNFujian Academy of Agricultural Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhizoma Alismatis (RA), widely known as "Ze-Xie" in China, is the tuber of

Identifiers

PMID31485369
PMCPMC6710727
OpenAlexW2968314543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.